Abbott Laboratories Corporation

Medline Industries, Inc.

Hoechst Marion Roussel

Aventis Pharmaceuticals Inc.

Pharmacia Corporation

Merrell Pharmaceuticals, Inc.

Baxter International Inc.

Baxter Healthcare Sa

Christopher R Dalton

Daryl Richard Sauer

George D Maynard

John M Kane

Milan Bruncko

Fortuna Haviv

David S Noskowicz

Elizabeth M Kudlacz

Scott Bedoe

Braulio Santiago

Brent Skupien

Pere Berkowitz

John T Randolph

James E Burgess

Jonathan Greer

Larry D Bratton

Nicholas A Mort

Michele A Kaminski

Lisa Marie Frey

Timothy Paul Burkholder

Bradley W Crawford

Boyd Lynn Harrison

Michael B Tollefson

James W Malecha

Todd Warren Rockway

James Ryan Burgess

Nizal S Chandrakumar

Vincent L Giranda

Jianchun Gong

George Ku

David M Stemerick

John H Kehne

Moshe Weitzberg

Jeffrey A White

Charles J Nichols

Vicki L Nienaber

Jennifer Ann Van Camp

Nguyen S Vo

Larry Don Bratton

Scott B Meikrantz

Phillip B Cox

Willian J McClellan

Philip Waid

William J Mcclellan

John D Kane

Bruce L Riser

A device for cleaning medical implements is disclosed, in particular a device for cleaning vascular or other fluid access sites. The device includes a cap having an opening to receive an access site. The cap may be used in the following manner: A healthcare worker may, with gloved hands, open the cap packaging and place the cap over the port of a medical implement to be cleaned. The healthcare worker may wipe the site by either applying a turning motion or by simply pushing the cap onto the port. The cap could then remain secured in place by threads other mechanisms. A cap in place on a medical implement may be a positive indication that a desired site of the medical implement is clean. The cap may include a disinfecting substance.

Disinfecting cap

A window dressing includes a primary layer having a window for viewing a catheter insertion site. The primary layer includes an adhesive layer on a lower, skin-contacting face of the primary layer. A transparent layer covers the window and adheres to the upper surface of the primary layer. An ultrasonic transmission layer is positioned below the primary layer, where the transmission layer comprises a layer of hydrogel. A support structure has a stiffness that is greater than the primary layer and has an adhesive layer on the lower surface of the support structure. The support structure adhesive layer adheres the support structure to the upper surface of the primary layer.

Window dressing for use with ultrasonic aid in venipuncture

The present invention is directed to selective LXR modulators, small molecule compounds corresponding to Formula I and is further directed to a process of treating a condition in a mammal that is modulated by LXR using a therapeutically effective dose of a compound of Formula I.

Aromatic thioether liver X-receptor modulators

Naphthamidine urokinase inhibitors

Disclosed are 3&prime;,3&prime;-N-bis-desmethyl-3&prime;-N-cycloalkyl-6-O-methyl-11-deoxy-11,12-cyclic carbamate erythromycin A derivatives which are antagonists of lutenizing hormone-releasing hormone (LHRH). Also disclosed are pharmaceutical compositions comprising the compounds, to methods of using the compounds and to the process of making the same.

3&prime;,3&prime;-N-bis-desmethyl-3&prime;-N-cycloalkyl erythromycin derivatives as LHRH antagonists

The present invention relates to novel substituted piperidine derivatives of formula (1), stereoisomers

Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases

The present invention relates to novel 4-(1H-benzimidazol-2-yl)&lsqb;1,4&rsqb;diazepane derivatives of formula (1):

Substituted 4-(1H-benzimidazol-2-yl)&lsqb;1,4&rsqb;diazepanes useful for the treatment of allergic disease

Disclosed are 3'-N-desmethyl-3'-N-susbstituted-6-O-methyl-11-deoxy-11,12-cyclic carbamate erythrolide A derivatives which are antagonists of luteinizing hormone-releasing hormone (LHRH). Also disclosed are pharmaceutical compositions comprising the compounds, to methods of using the compounds and to the process of making the same.

Macrolide LHRH antagonists

Disclosed are 3',3'-N-bisdesmethyl-3',3'-N-bis-substituted-6-O-methyl-11-deoxy-11,12-cyc lic carbamate erythromycin A derivatives which are antagonists of lutenizing hormone-releasing hormone (LHRH). Also disclosed are pharmaceutical compositions comprising the compounds, to methods of using the compounds and to the process of making the same.

3',3-N-bis-substituted macrolide LHRH antagonists

Disclosed are 3'-N-desmethyl-3'-N-substituted-6-O-methyl-11-deoxy-11,12-cyclic carbamate erythromycin A derivatives which are antagonists of lutenizing hormone-releasing hormone (LHRH). Also disclosed are pharmaceutical compositions comprising the compounds, to methods of using the compounds and to the process of making the same.

The present invention relates to novel N-methyl-N-(4-(4-(1H-benzimidazol-2-yl)�1,4!diazepan-1-yl)-2-(aryl)butyl)b enzamide derivatives of the formula: ##STR1## stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonists. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.

Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl)

The present invention relates to novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl )benzamide derivatives of the formula: ##STR1## stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonists. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.

Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino)

Growing community of inventors

Mundelein, IL, United States of America

Christopher R Dalton